BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 12559968)

  • 1. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.
    Whittemore LA; Song K; Li X; Aghajanian J; Davies M; Girgenrath S; Hill JJ; Jalenak M; Kelley P; Knight A; Maylor R; O'Hara D; Pearson A; Quazi A; Ryerson S; Tan XY; Tomkinson KN; Veldman GM; Widom A; Wright JF; Wudyka S; Zhao L; Wolfman NM
    Biochem Biophys Res Commun; 2003 Jan; 300(4):965-71. PubMed ID: 12559968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice.
    Tang L; Yan Z; Wan Y; Han W; Zhang Y
    Muscle Nerve; 2007 Sep; 36(3):342-8. PubMed ID: 17587222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cachexia in mice by systemically administered myostatin.
    Zimmers TA; Davies MV; Koniaris LG; Haynes P; Esquela AF; Tomkinson KN; McPherron AC; Wolfman NM; Lee SJ
    Science; 2002 May; 296(5572):1486-8. PubMed ID: 12029139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic strategies for muscular dystrophy by myostatin inhibition].
    Sunada Y
    Rinsho Shinkeigaku; 2006 Nov; 46(11):942-4. PubMed ID: 17432227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
    FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of a monoclonal anti-myostatin antibody and the effects of in ovo administration of the antibody on posthatch broiler growth and muscle mass.
    Kim YS; Bobbili NK; Paek KS; Jin HJ
    Poult Sci; 2006 Jun; 85(6):1062-71. PubMed ID: 16776476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin: a therapeutic target for skeletal muscle wasting.
    Roth SM; Walsh S
    Curr Opin Clin Nutr Metab Care; 2004 May; 7(3):259-63. PubMed ID: 15075916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of myostatin activity and muscle growth.
    Lee SJ; McPherron AC
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9306-11. PubMed ID: 11459935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload.
    Shi C; Zijlstra SN; de Wit S; Meijers WC; Aboumsallem JP; Silljé HHW; de Boer RA
    Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H195-H201. PubMed ID: 37294894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
    Chen JL; Walton KL; Hagg A; Colgan TD; Johnson K; Qian H; Gregorevic P; Harrison CA
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5266-E5275. PubMed ID: 28607086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a follistatin-derived myostatin inhibitory peptide.
    Saitoh M; Takayama K; Hitachi K; Taguchi A; Taniguchi A; Tsuchida K; Hayashi Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126892. PubMed ID: 31874826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin: a modulator of skeletal-muscle stem cells.
    Walsh FS; Celeste AJ
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1513-7. PubMed ID: 16246158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.
    McPherron AC; Lawler AM; Lee SJ
    Nature; 1997 May; 387(6628):83-90. PubMed ID: 9139826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.
    Wolfman NM; McPherron AC; Pappano WN; Davies MV; Song K; Tomkinson KN; Wright JF; Zhao L; Sebald SM; Greenspan DS; Lee SJ
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15842-6. PubMed ID: 14671324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
    Bogdanovich S; McNally EM; Khurana TS
    Muscle Nerve; 2008 Mar; 37(3):308-16. PubMed ID: 18041051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral content and density in the humerus of adult myostatin-deficient mice.
    Hamrick MW; McPherron AC; Lovejoy CO
    Calcif Tissue Int; 2002 Jul; 71(1):63-8. PubMed ID: 12060865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.